4-Methoxybenzyl Bromide - CAS 2746-25-0
Catalog: |
BB019573 |
Product Name: |
4-Methoxybenzyl Bromide |
CAS: |
2746-25-0 |
Synonyms: |
1-(bromomethyl)-4-methoxybenzene; 1-(bromomethyl)-4-methoxybenzene |
IUPAC Name: | 1-(bromomethyl)-4-methoxybenzene |
Description: | 4-Methoxybenzyl Bromide (CAS# 2746-25-0) is a useful reactant in studying diarylpyrazoles as cyclooxygenase 2 inhibitors. |
Molecular Weight: | 201.06 |
Molecular Formula: | C8H9BrO |
Canonical SMILES: | COC1=CC=C(C=C1)CBr |
InChI: | InChI=1S/C8H9BrO/c1-10-8-4-2-7(6-9)3-5-8/h2-5H,6H2,1H3 |
InChI Key: | GIGRWGTZFONRKA-UHFFFAOYSA-N |
Boiling Point: | 91 °C (1 mmHg) |
Density: | 1.379 g/cm3 |
MDL: | MFCD00800380 |
LogP: | 2.59010 |
GHS Hazard Statement: | H314 (100%): Causes severe skin burns and eye damage [Danger Skin corrosion/irritation] |
Precautionary Statement: | P260, P264, P280, P301+P330+P331, P303+P361+P353, P304+P340, P305+P351+P338, P310, P321, P363, P405, and P501 |
Signal Word: | Danger |
Publication Number | Title | Priority Date |
WO-2021127499-A1 | Protein tyrosine phosphatase inhibitors and methods of use thereof | 20191218 |
US-2021171481-A1 | Benzothia(di)azepine compounds and their use as bile acid modulators | 20191204 |
US-2021171482-A1 | Benzothia(di)azepine compounds and their use as bile acid modulators | 20191204 |
US-2021171483-A1 | Benzothiadiazepine compounds and their use as bile acid modulators | 20191204 |
WO-2021110883-A1 | Benzothia(di)azepine compounds and their use as bile acid modulators | 20191204 |
PMID | Publication Date | Title | Journal |
21522670 | 20101218 | 5-[(4-Meth-oxy-benz-yl)sulfan-yl]-2-methyl-1,3,4-thia-diazole | Acta crystallographica. Section E, Structure reports online |
21579520 | 20100526 | 3-(4-Methoxy-benz-yl)-1-benzothio-phene | Acta crystallographica. Section E, Structure reports online |
21579467 | 20100519 | 2-[4-Chloro-3-(4-ethoxy-benz-yl)phen-yl]-1,3-dithiane | Acta crystallographica. Section E, Structure reports online |
19916554 | 20100114 | Structure-based design of pteridine reductase inhibitors targeting African sleeping sickness and the leishmaniases | Journal of medicinal chemistry |
19105725 | 20090101 | Distributed Drug Discovery, Part 2: global rehearsal of alkylating agents for the synthesis of resin-bound unnatural amino acids and virtual D(3) catalog construction | Journal of combinatorial chemistry |
Complexity: | 87.3 |
Compound Is Canonicalized: | Yes |
Covalently-Bonded Unit Count: | 1 |
Defined Atom Stereocenter Count: | 0 |
Defined Bond Stereocenter Count: | 0 |
Exact Mass: | 199.98368 |
Formal Charge: | 0 |
Heavy Atom Count: | 10 |
Hydrogen Bond Acceptor Count: | 1 |
Hydrogen Bond Donor Count: | 0 |
Isotope Atom Count: | 0 |
Monoisotopic Mass: | 199.98368 |
Rotatable Bond Count: | 2 |
Topological Polar Surface Area: | 9.2 Å2 |
Undefined Atom Stereocenter Count: | 0 |
Undefined Bond Stereocenter Count: | 0 |
XLogP3: | 2.5 |
Online Inquiry
Customer Support
Customer Centered
Related Functional Groups
Halides
Customers Also Viewed
INDUSTRY LEADERS TRUST OUR PRODUCTS